New amendment allows BC optometrists treat glaucoma

Article

The British Columbia Association of Optometrists (BCAO) has added to the Amendments to the Optometrists Regulation to allow optometrists to treat glaucoma.

In a move that will make the treatment of glaucoma easier and more efficient in British Columbia, BC Doctors of Optometry will now be able to prescribe medications for the treatment of glaucoma. The addition to the Amendments to the Optometrists Regulation started to take effect on August 2, 2012. Prior to this move, it wasn't uncommon for a patient to need to travel over one thousand kilometers to receive treatment for glaucoma.

Dr. Surginder Sahora, the president of the British Columbia Association of Optometrists (BCAO), commented on the change,

"By allowing Doctors of Optometry to prescribe anti-glaucoma medications, patients will have greater access to timely and appropriate eye care in all areas of the province. Doctors of Optometry are educated and certified to diagnose and to prescribe treatment for glaucoma. The recent changes allow them to practice what they are already certified to do."

For more information on the BC authorization to treat glaucoma, read the full press release.


Related Articles

British Columbia's optometrists are angling for glaucoma priviledges (May 1, 2012)

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.